News & Updates
Showing Cardiology articles
Showing
Fibrosis-4 index predicts cardiovascular events in NAFLD
The fibrosis-4 index (FIB-4) is strongly and independently associated with major adverse cardiovascular events (MACE), beyond established cardiovascular risk factors and baseline liver diagnosis, among patients with nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), or at risk of NASH, a study in the real-world setting has shown.
DOAC use persists in NVAF patients with liver disease
A knowledge gap exists on the effects of direct oral anticoagulants (DOACs), but most nonvalvular atrial fibrillation (NVAF) patients with liver disease still begin treatment with these medications, particularly apixaban and rivaroxaban, a study has found.
Antihypertensive drugs up risk of psoriasis
Use of antihypertensive medications is associated with the incidence of psoriasis, reports a study. Beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers (CCBs), and thiazide diuretics result in an increased risk of psoriasis.
Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI
Free triiodothyronine (FT3) and free thyroxine (FT4) independently predict in-hospital cardiogenic shock (CS) incidence among patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI), reports a recent study.
